Navigation Links
Crisalix Awarded as a Leading Life Science Company that is Revolutionizing the Medical Industry
Date:12/12/2012

Lausanne, Switzerland (PRWEB) December 12, 2012

Crisalix, amongst “the best-of-the-best at the 2012 European Venture Contest” [Europe Unlimited]

The European Venture Contest (EVC) held in Berlin is the largest meeting point for innovative entrepreneurs in the Information & Communications Technology (ICT), Life Sciences and Cleantech sectors. The EVC plays an important role in finding, evaluating and recognizing world-class innovative companies to accelerate their growth by providing access to top-level international partners, and supporting these global leaders of tomorrow by updating the skill set needed to grow their business successfully.

The EVC brings together over 300 top tier venture investors as well as corporate investors from multinationals such as IBM, Roche, Microsoft, Philips, SAP and more. Through 10 rounds of presentations and shortlisting which took place over one year across the main European countries, from an initial 800+ companies the jury made a final selection of the top 10 companies which included Crisalix as one of the only three Life Science companies offering novel technologies, products and services that are expected to dramatically impact their respective industry over the coming years.

This award from top international investors based on specific criteria related to business potential, product merit, competitive positioning and project profile quality amongst others, confirms Crisalix’s position as a leader and pioneer in the field of Aesthetics. It is recognition for the potential that Crisalix represents today and for the years ahead.

About Crisalix

If you were considering modifying your physical appearance, wouldn’t you be wondering “how could I look after the procedure?” Crisalix is a worldwide leader in easy 3D aesthetic simulations based on standard digital photos which provides an answer to the first and foremost question every aesthetic patient asks their physician. With the first cloud solution and SaaS business model for 3D simulations of aesthetic procedures and plastic surgery, Crisalix brings together the latest advancements in surgical and aesthetic technology, 3D and information technology. Crisalix has already enabled physicians in over 70 countries to increase the care and treatment provided to their patients thanks to its unique 3D simulation technology based on regular 2D photos.

Crisalix has been recommended by The International Confederation for Plastic, Reconstructive, and Aesthetic Surgery (IPRAS) for its contribution to improving the care and treatment of patients around the world seeking aesthetic procedures.

Further information

Patients interested in breast augmentation or aesthetic procedures should schedule a consultation by finding the nearest physician offering Crisalix simulations using the Aesthetic Professional Directory.

Physicians interested in incorporating Crisalix 3D simulations in their aesthetic consultations should directly open an account on: http://crisalix.com/en

Press contacts: Nandan Sampatkumar
Tel: (00 41) 21 693 90 01
Email: press(at)crisalix(dot)com
Website: http://www.crisalix.com

Read the full story at http://www.prweb.com/releases/Crisalix3DSimulations/EVCcontest/prweb10227466.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plant Sensory Systems Awarded $1.8 Million from ARPA-E to Engineer Beets for Biofuel
2. Ben-Gurion University awarded $6.5 million grant to develop nano thin infrared night vision glasses
3. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
4. WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
5. Stanford faculty awarded $2.2 million for innovative energy research
6. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response
7. Avery-Landsteiner Prize for Immunology Awarded to Alain Fischer of Paris, France, by German Society for Immunology
8. Trellis Bioscience Awarded SBIR Grant to Advance CMV Program
9. Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
10. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
11. Elusys Awarded Additional $50.2 Million Under An Exisiting U.S. Government Contract To Support Final Stages Of Development Of ETI-204, For Treatment Of Inhalational Anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Madison, Wisconsin (PRWEB) , ... February 23, 2017 ... ... their Drug Discovery Services portfolio to include an array of biochemical ... clients with reliable data to drive their hit-to-lead and SAR programs, including inhibitor ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, Inc , (GGI) ... Compass Research . GGI's mission is to advance global health and highlight the greater ... in honor of each clinical trial volunteer. The vision of GGI is to serve ...
(Date:2/22/2017)... Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on ... companion animals, will host a live conference call on Tuesday, ... results from the fourth quarter and full year ended December ... access the audio webcast or use the conference ... ...
Breaking Biology Technology:
(Date:2/9/2017)... The biomass boiler market report by Transparency Market Research ... in terms of revenue (US$ Mn) based on the ... boilers has been segmented on the basis of feedstock ... based on feedstock type, has been segmented into woody ... urban residues, and others. On the basis of product ...
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 ... Driven largely by the confluence of organizations, desires ... distaste for knowledge-based systems (password and challenge questions), ... industrial, and government systems. The market is driven ... a demarcation between consumer and enterprise uses cases, ...
Breaking Biology News(10 mins):